There are significant discrepancies in clinical data regarding the nuclear/cytoplasmic distribution of BRCA1 in breast cancer [4, 9–11] and lack of knowledge regarding whether BRCA1 expression level or its nuclear localization is the primary contributing factor to breast cancer development and progression. The gene discussed is BRCA1; the disease is breast carcinoma.